μν μ€μ IR
Channel@alteogenir
μ£Όμνμ¬ μν μ€μ (Alteogen Inc.)μ IR/PR μ±λμ λλ€.
Measured performance snapshot
Only crawler-observed values are shown. Missing history stays missing instead of becoming zero.
- Members
- 9,790 At last successful crawl
- Average post views
- 15,289 Sampled public posts
- Sampled ERR
- 156.17% Average views Γ· members
- 7-day growth
- Not enough data Complete 7-day baseline required
- 30-day growth
- Not enough data Complete 30-day baseline required
- 90-day growth
- Not enough data Complete 90-day baseline required
Member growth
The growth chart appears once our crawler has recorded at least two member checkpoints for this channel. Fresh listings fill in within a few days.
Data quality passport
Freshness: stale Β· Classification: automatic Β· Confidence: 42%
Audience authenticity, audience country and Telegram Ads approval are not verified. Sampled views are not normalized by post age and are not a guarantee of engagement.
Inventory limits: non ad topic; low classification confidence; outside internal inventory; stale profile.
Save or compare this channelClaim or correct this profileAbout this channel
μ£Όμνμ¬ μν μ€μ (Alteogen Inc.)μ IR/PR μ±λμ λλ€.
Recent posts
Public feed sample. Captured: 2026-09-14T15:02:55.320051. This is not a live feed.
μλ νμΈμ. λΉμ¬μ ννΈλ μ ν 'ν€νΈλ£¨λ€ νλ μ€'μ λ§€μΆμ΄ μλ 9μ λ§ μΆμ ν λΉ λ₯΄κ² μ±μ₯νλ©° μ¬ν΄ μ°κ° 2μ‘°μμ λμ΄μ€ κ²μΌλ‘ μ λ§λκ³ μμ΅λλ€. μν μ€μ μ μμ νλ μ νμ ν΅ν΄ κΎΈμ€ν νλ§€ λ§μΌμ€ν€ μ μ μ κΈ°λν μ μκ³ ν₯ν μνν¬, λνΌμ νΈ, μνμ§, μ ¬νΌλ¦¬ λ± μ§μμ μΈ λΈλ‘λ²μ€ν°κΈ ννΈλ μ ν νλκ° μμ λμ΄ μμ΅λλ€. νλ μ€ λ§€μΆ κ΄λ ¨λ κΈ°μ¬ μλμ κ°μ΄ 곡μ λ립λλ€. https://n.news.naver.com/article/008/0005413359?sid=101
https://www.astrazeneca.com/media-centre/press-releases/2026/enhertu-in-DESTINY-Lung04-Phase-iii-trial.html
μλ νμΈμ. λΉμ¬μ ννΈλμ ν μνν¬(Enhertu)κ° HER2 λ³μ΄ μ§νμ± λΉμμΈν¬νμ(HER2-mutant advanced non-small cell lung cancer) νμλ₯Ό λμμΌλ‘ ν μμ3μμμ κΈμ μ μΈ κ²°κ³Όλ₯Ό λ°ννλ©° 1μ°¨ μΉλ£μ μ κ°λ₯μ±μ νμΈνλ€κ³ λ°νμ΅λλ€. βΆοΈ μ£Όνκ°λ³μ(primary endpoint)μΈ λ¬΄μ§ν μμ‘΄κΈ°κ° μ€μκ°(median PFS) 14.3κ°μ vs. νμ¬ 1μ°¨ νμ€μΉλ£μλ²(ν€νΈλ£¨λ€+ννμλ²) 8.3κ°μ β 6κ°μ μ°μ₯ & μ§λ³ μ§ν λλ μ¬λ§μν 37% κ°μ βΆοΈ Enhertu ORR 70.0% vs. 1μ°¨ νμ€μΉλ£μλ² 44β¦
μλ νμΈμ. λΉμ¬μ ννΈλ μ ν ' ν€νΈλ£¨λ€ νλ μ€(Keytruda Qlex) 'μ μ§λ λ¬(8μ) λΈλ£Έλ²κ·Έ WAC μ€μ μ΄ μ λ°μ΄νΈλμ΄ κ³΅μ λ립λλ€. βΆοΈ 8μ WAC: $232.3M (μ½ 3,122μ΅μ, μ§μ μ λλΉ μ½ 14.3% μ¦κ°) βΆοΈ ν€νΈλ£¨λ€ νλμ°¨μ΄μ¦ μ€ μ μ μ¨: 12.7% (μ§μ μ 10.5% λλΉ 2.2%p μ¦κ°) βΆοΈ 1~8μ λμ μΆμ λ§€μΆμ‘: $1,026M ($590M β MSD λ°ν μλ°κΈ° λ§€μΆ + $436M β λΈλ£Έλ²κ·Έ WAC μ€μ ) β 8κ°μ λμ λ§€μΆλ‘ $1 billion(μ½ 1.34μ‘°μ) μ΄κ³Ό λ¬μ±ν κ²μΌλ‘ μΆμ λΌ μΆμ 11κ°μλ§μ β¦
μλ νμΈμ. λΉμ¬λ₯Ό 컀λ²νλ CLSAμμ λͺ©νμ£Όκ°λ₯Ό 46λ§μ(κΈ°μ‘΄ μ½ 38λ§μ)μΌλ‘ μν₯ν 리ν¬νΈκ° μ λ°μ΄νΈλμ΄ μ£Όμ λ΄μ© 곡μ λ립λλ€. βΆοΈ μ κ· Novartis λΌμ΄μ μ€ κ³μ½μ λ°λΌ λ°Έλ₯μμ΄μ 3.4μ‘°μ μΆκ° -> ALT-B4κ° λ€μν modalityμ νλ μ μ© (CLSAμ Novartis μ»€λ² μ λ리μ€νΈ Davidλ κ³μ½μ AOC μ νλ€μ΄ ν¬ν¨λμ κ²μΌλ‘ μΆμ ) βΆοΈ Novartis κ³μ½μ μν μ€μ μ νμ΄λΈλ‘μμ νλ«νΌμ 10λ²μ§Έ λμ΄μ μ¬ν΄ 4λ²μ§Έ κ³μ½μ -> ALT-B4λ λ리 μΈμ λ°κ³ μκ³ μ κ· λΌμ΄μ μ€ κ³μ½λ€λ‘ μ₯κΈ° κΈ°μ κ°μΉλ₯Ό κ·Ήλννκ³ μμ βΆοΈ PTβ¦
Frequently asked questions
How many members does μν μ€μ IR have?
As of our latest crawl on 2026-09-04, the channel reports about 9,790 members. The count refreshes automatically every time we re-check the profile.
How do I join μν μ€μ IR on Telegram?
Tap βOpen in Telegramβ above β it opens the official t.me page for @alteogenir, where you can press Join inside Telegram.
Is joining μν μ€μ IR free?
Yes. Public Telegram channels are free to join; only your normal internet data usage applies.
What content does it publish?
The owner describes it as: βμ£Όμνμ¬ μν μ€μ (Alteogen Inc.)μ IR/PR μ±λμ λλ€.β